Advisory in the preclinical and clinical development (early stage, phases 1 and 2) of new compounds.
The Neuron Experts team (operational and scientific) provides support and advices in your R&D programs and also in the development of new molecules in specific disease indications.
OUR EXPERTISE CONSISTS IN LEADING NEW MOLECULES (LEAD COMPOUNDS) WITH HIGH POTENTIAL IN CANDIDATE MOLECULES STATUS
Based on our expertise, neuron experts provides advice in the following areas:
In cell culture models in neurology;
In neuro-pharmacology, neurodegenerative diseases;
In preclinical development of new drugs in neurology;
In clinical development (early stage Ph1-Ph2) of new candidates in neurodegeneratives diseases;
In regulatory requirement (FDA, EMEA…).
|